# Paricalcitol Injection Phase II Trial

> **NCT00646932** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 25 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** paricalcitol
- **DRUG:** paricalcitol
- **DRUG:** paricalcitol
- **DRUG:** paricalcitol

## Key facts

- **NCT ID:** NCT00646932
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-02
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2008-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00646932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00646932, "Paricalcitol Injection Phase II Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00646932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*